beta-lapachone has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisenbeis, VB | 1 |
| Qiu, D | 1 |
| Gorka, O | 1 |
| Strotmann, L | 1 |
| Liu, G | 1 |
| Prucker, I | 1 |
| Su, XB | 1 |
| Wilson, MSC | 1 |
| Ritter, K | 1 |
| Loenarz, C | 1 |
| Groß, O | 1 |
| Saiardi, A | 1 |
| Jessen, HJ | 1 |
1 other study available for beta-lapachone and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
β-lapachone regulates mammalian inositol pyrophosphate levels in an NQO1- and oxygen-dependent manner.
Topics: Adenosine Triphosphate; Cell Line, Tumor; Diabetes Mellitus, Type 2; Diphosphates; Humans; Hydrogen | 2023 |